Skip to content
Parakho

Ind-Swift Laboratories Ltd

NSE INDSWFTLABBSE 532305

Q1 FY27, unaudited

Revenue
₹191.45 Cr
Profit after tax
₹24.68 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations191.45+25.35%641.29
Other income7.65−47.52%46.97
Total income199.11+19.00%688.26
Employee benefit expense39.56+21.61%137.98
Finance costs0.71−38.75%1.40
Depreciation & amortisation7.58+13.57%30.61
Total expenses166.31+5.95%628.21
Profit before tax32.56+214.48%49.05
Tax expense7.99+368.48%7.73
Profit after tax24.68+181.32%41.42
Total comprehensive income24.77+182.25%40.54
Earnings per share
Earnings per share, basic₹2.84₹4.95
Earnings per share, diluted₹2.84₹4.84

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

A transcript for the Q1 FY27 call was filed with the exchange; Parakho has not summarised it yet.

All quarters

Filings

12 shown · 43 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.